| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |